miR-494 in Extracellular Vesicles as a Potent Biomarker of Chronic Myeloid Leukemia Treatment with Tyrosine Kinase Inhibitors.
Tatsuki ShibutaHonoka ShimizuYukichi TakadaAsuka FukuSatoshi TomiyasuTsukuru Umemura
Hemato
3
2
373
384